Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Interaction of Diphenylhydantoin (Phenytoin) and Phenobarbital with Hormonal Mediation of Fetal Rat Bone Resorption In Vitro
Theodore J. Hahn, … , Arnold J. Kahn, Steven L. Teitelbaum
Theodore J. Hahn, … , Arnold J. Kahn, Steven L. Teitelbaum
Published August 1, 1978
Citation Information: J Clin Invest. 1978;62(2):406-414. https://doi.org/10.1172/JCI109142.
View: Text | PDF
Research Article

Interaction of Diphenylhydantoin (Phenytoin) and Phenobarbital with Hormonal Mediation of Fetal Rat Bone Resorption In Vitro

  • Text
  • PDF
Abstract

Chronic administration of high doses of anticonvulsant drugs frequently produces classic osteomalacia with bone histologic changes characteristic of increased parathyroid hormone (PTH) effect in man. However, several reports have documented defects in calcified tissue metabolism suggestive of an end-organ resistance to PTH after chronic anticonvulsant drug therapy. To examine the direct action of anticonvulsant drugs on bone resorption, we investigated the effects of diphenylhydantoin (phenytoin) (DPH) (100-200 μg/ml) and phenobarbital (10-400 μg/ml) on basal and hormonally mediated resorption 5-day cultures of fetal rat forelimb rudiments. In this system both drugs significantly inhibited basal and PTH-stimulated 45Ca and [3H]hydroxyproline release, as well as 1,25-dihydroxyvitamin D3-stimulated 45Ca release. The effects of DPH and phenobarbital were additive, with DPH exhibiting a several-fold more potent inhibitory effect than phenobarbital. Whereas DPH exhibited a striking synergism with the inhibitory effects of human calcitonin (HCT) on PTH-induced resorption, the effect of phenobarbital was merely additive to that of HCT. PTH and PTH plus HCT-induced increases in bone cyclic AMP (cAMP) content were significantly inhibited by DPH but not by phenobarbital. However, in contrast to effects on 45Ca release, DPH inhibition of cAMP generation was not accentuated in the presence of HCT. It is concluded that: (a) both DPH and phenobarbital can directly inhibit basal and hormonally stimulated bone resorption, with DPH being much more potent in this regard; (b) DPH appears to inhibit bone resorption via a cAMP-independent mechanism and has an additional suppressive effect on PTH-induced cAMP generation; and (c) the synergistic interaction of DPH and HCT in inhibiting 45Ca release occurs at a site independent of cAMP generation.

Authors

Theodore J. Hahn, Cheryl R. Scharp, Catherine A. Richardson, Linda R. Halstead, Arnold J. Kahn, Steven L. Teitelbaum

×

Total citations by year

Year: 2023 2020 2019 2016 2014 2013 2012 2011 2010 2008 2007 2006 2005 2004 2001 2000 1999 1997 1995 1994 1990 1989 1988 1986 1985 1984 1983 1982 1981 1980 1979 Total
Citations: 1 3 1 1 3 1 3 2 2 2 2 2 5 3 1 2 1 2 4 1 2 1 3 1 1 2 5 7 3 4 7 78
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (78)

Title and authors Publication Year
Bone Turnover Markers: Basic Biology to Clinical Applications.
Schini M, Vilaca T, Gossiel F, Salam S, Eastell R
Endocrine reviews 2023
Effects of zonisamide monotherapy on bone health in drug‐naive epileptic patients
DL Koo, H Nam
Epilepsia 2020
Bilateral Acetabular Fractures Associated with Seizures: A Report of 2 Cases
K Yngstrom, E Stapleton, Z Aberman, D Galos
JBJS Case Connector 2020
Bone health in pediatric patients with neurological disorders
A Ko, J Kong, F Samadov, A Mukhamedov, YM Kim, YJ Lee, SO Nam
Annals of Pediatric Endocrinology & Metabolism 2020
Phenobarbital inhibits osteoclast differentiation and function through NF-κB and MAPKs signaling pathway
W Wang, Y Gao, W Zheng, M Li, X Zheng
International Immunopharmacology 2019
Exposure to Excess Phenobarbital Negatively Influences the Osteogenesis of Chick Embryos
Y Yan, X Cheng, RH Yang, H Li, JL Chen, ZL Ma, G Wang, M Chuai, X Yang
Frontiers in pharmacology 2016
Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy
DL Koo, KJ Hwang, SW Han, JY Kim, EY Joo, WC Shin, HW Lee, DW Seo, SB Hong
Epilepsy Research 2014
Bone Status in Patients with Epilepsy: Relationship to Markers of Bone Remodeling
SA Hamed, EM Moussa, AH Youssef, MA ElHameed, E NasrEldin
Frontiers in neurology 2014
The problem of osteoporosis in epileptic patients taking antiepileptic drugs
B Miziak, B Błaszczyk, M Chrościńska-Krawczyk, G Danilkiewicz, E Jagiełło-Wójtowicz, SJ Czuczwar
Expert Opinion on Drug Safety 2014
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich
Seldin and Giebisch's The Kidney 2013
May Long Term Oxcarbazepine Treatment Be Lead to Secondary Hyperparathyroidism?
O Babacan, A Karaoglu, S Vurucu, E Yesilkaya, O Yesilyurt, T Cayci, M Gulgun, B Unay, R Akın, O Ozcan
Journal of clinical neurology (Seoul, Korea) 2012
Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy
DL Koo, EY Joo, D Kim, SB Hong
Epilepsy Research 2012
Generalised stunting of roots in an epileptic child: is long-term phenytoin therapy the cause?
G Jindal, RK Pandey, D Kumar
BMJ case reports 2012
Neuroendocrinological aspects of epilepsy: Important issues and trends in future research
AM Pack, DS Reddy, S Duncan, A Herzog
Epilepsy & Behavior 2011
Influences of bone and mineral metabolism in epilepsy
SA Hamed
Expert Opinion on Drug Safety 2011
Bone and calcium metabolism and antiepileptic drugs
A Verrotti, G Coppola, P Parisi, A Mohn, F Chiarelli
Clinical Neurology and Neurosurgery 2010
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
Evaluation of Bone Turnover in Epileptic Children Using Oxcarbazepine
A Cansu, E Yesilkaya, A Serdaroğlu, TL Hırfanoğlu, O Çamurdan, Ö Gülbahar, K Gücüyener, P Cinaz
Pediatric Neurology 2008
Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy
AM Pack, MJ Morrell, A Randall, DJ McMahon, E Shane
Neurology 2008
Adverse effects of antiepileptic drugs on bone mineral density in children
T Gissel, CS Poulsen, P Vestergaard
Expert Opinion on Drug Safety 2007
Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy
CA Kulak, VZ Borba, CE Silvado, L Paola, MJ Seibel, JP Bilezikian, CL Boguszewski
Arquivos brasileiros de endocrinologia e metabologia 2007
Dynamics of Bone and Cartilage Metabolism
JE Mulder, CA Kulak, E Shane
Dynamics of Bone and Cartilage Metabolism 2006
Adverse Effects of Antiepileptic Drugs on Bone Mineral Density
A Babayigit, E Dirik, E Bober, H Cakmakcı
Pediatric Neurology 2006
Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy
AM Pack, MJ Morrell, R Marcus, L Holloway, E Flaster, S Do�e, A Randall, C Seale, E Shane
Annals of Neurology 2005
Epilepsy, osteoporosis and fracture risk - a meta-analysis
P Vestergaard
Acta Neurologica Scandinavica 2005
International Review of Neurobiology
ZT Bloomgarden
International review of neurobiology 2005
Bilateral Acetabular Fractures Associated With a Seizure: A Case Report
R Friedberg, J Buras
Annals of Emergency Medicine 2005
Use of phenytoin for the long-term treatment of partial seizures: Results of a survey conducted during the 2004 meeting of the American Academy of Neurology
B Smith
Current Therapeutic Research 2005
Fracture Risk Associated with Use of Antiepileptic Drugs
P Vestergaard, L Rejnmark, L Mosekilde
Epilepsia 2004
Antiepileptic drugs and reduced bone mineral density
II Ali, L Schuh, GL Barkley, JR Gates
Epilepsy & Behavior 2004
Pathophysiology of bone loss in patients receiving anticonvulsant therapy
LA Fitzpatrick
Epilepsy & Behavior 2004
Adverse Effects of Antiepileptic Drugs on Bone Structure: Epidemiology, Mechanisms and Therapeutic Implications
AM Pack, MJ Morrell
CNS Drugs 2001
Phenyioin and Its Metabolite, 5-(4-Hydroxyphenyl)-5-Phenylhydantoin, Show Bone Resorption in Cultured Neonatal Mouse Calvaria
A Takahashi, K Onodera, H Shinoda, H Mayanagi
The Japanese Journal of Pharmacology 2000
Bone mineral density, vitamin D and anticonvulsant therapy
S Filardi, CA Guerreiro, LA Magna, JF Neto
Arquivos de Neuro-Psiquiatria 2000
Fracture risk is increased in epilepsy
P Vestergaard, S Tigaran, L Rejnmark, C Tigaran, M Dam, L Mosekilde
Acta Neurologica Scandinavica 1999
Osteoporosis
DL Glaser, FS Kaplan
Spine 1997
Endocrinology of Critical Disease
KP Ober
1997
Drug-Induced Metabolic Bone Disease
M Wolinsky-Friedland
Endocrinology and metabolism clinics of North America 1995
Phenytoin and fluoride act in concert to stimulate bone formation and to increase bone volume in adult male rats
T Ohta, JE Wergedal, T Matsuyama, DJ Baylink,
Calcified Tissue International 1995
Barbiturate and bone resorption
M Petrovic, G Cournot
Calcified Tissue International 1995
Low dose phenytoin is an osteogenic agent in the rat
T Ohta, JE Wergedal, HE Gruber, DJ Baylink,
Calcified Tissue International 1995
Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs
MJ Välimäki, M Tiihonen, K Laitinen, R Tähtelä, M Kärkkäinen, C Lamberg-Allardt, P Mäkelä, R Tunninen
Journal of Bone and Mineral Research 1994
The Effect of Phenytoin on Collagenase and Gelatinase Activities in UMR 106-01 Rat Osteoblastic Osteosarcoma Cells
AT Vernillo, NS Ramamurthy, HM Lee, BR Rifkin
Matrix 1990
The effect of phenytoin on parathyroid hormone stimulated cAMP activity in cultured murine osteoblasts
JM Auszmann, AT Vernillo, AS Fine, BR Rifkin
Life Sciences 1990
Reduction of the Teratogenic Effects of Phenytoin by Folic Acid and a Mixture of Folic Acid, Vitamins, and Amino Acids: A Preliminary Trial
M Zhu, S Zhou
Epilepsia 1989
Insulin and glucose regulation of glycogen synthase in rat calvarial osteoblastlike cells
EA Ituarte, HG Ituarte, TJ Hahn
Calcified Tissue International 1988
The effects of phenytoin on calcium uptake in osteoblastic cells
R Dziak, A Vernillo, B Rifkin
Journal of Bone and Mineral Research 1988
Glucose transport in osteoblast-enriched bone explants: Characterization and insulin regulation
TJ Hahn, SL Westbrook, TL Sullivan, WG Goodman, LR Halstead
Journal of Bone and Mineral Research 1988
Effect of phenytoin on rat bone resorption in vitro
MJ Somerman, BR Rifkin, S Pointon-Miska, WY Au
Archives of Oral Biology 1986
Diphenylhydantoin inhibits parathyroid hormone and prostaglandin E2-stimulated bone resorption in mouse calvaria without affecting cyclic AMP formation
U Lerner, BB Fredholm, L Hangstrom
Journal of Oral Pathology and Medicine 1985
Direct Effects of Diphenylhydantoin (Phenytoin) on the Ion-Transporting ATPases of Cultured Osteoblast-like Cells
RE Anderson, DM Woodbury
Epilepsia 1984
Phosphate and Mineral Metabolism
SG Massry, G Maschio, E Ritz
1984
Serum dihydroxyvitamin d metabolite concentrations in patients on chronic anticonvulsant drug therapy: Response to pharmacologic doses of vitamin D2
TJ Hahn, R Shires, LR Halstead
Metabolic Bone Disease and Related Research 1983
Oncogenic hypophosphatemic osteomalacia
ZS Agus
Kidney International 1983
Does carbamazepine cause disturbances in calcium metabolism in epileptic patients?
L Tjellesen, L Nilas, C Christiansen
Acta Neurologica Scandinavica 1983
Inhibition of bone resorption in tissue culture by H1-receptor antagonists
P Goldhaber, L Rabadjija
American journal of physiology. Endocrinology and metabolism 1983
A quantitative determination of anticonvulsant-induced bone demineralization by an improved X-ray densitometry technique
K Wolschendorf, K Vanselow, , H Schulz
Neuroradiology 1983
On the pathogenesis of anticonvulsant-drug-induced alterations of calcium metabolism
K Kruse
European Journal of Pediatrics 1982
Comparison of parathyroid hormone and calcium ionophore A23187 effects on bone resorption and nucleic acid synthesis in cultured fetal rat bone
TF DeBartolo, LE Pegg, C Shasserre, TJ Hahn
Calcified Tissue International 1982
Inhibition of 1α-hydroxy-vitamin D3stimulated bone resorption in tissue culture by the calcium antagonist verapamil
U Lerner, GT Gustafson
European Journal of Clinical Investigation 1982
Influence of Diphenylhydantoin on Isotope Release and Bone EnzymesIn Vitro
JG Pedersen, BJ Lund, I Reimann
Acta Orthopaedica 1982
Reduced bone growth in rats treated with anticonvulsant drugs: A type II pseudohypoparathyroidism?
PB Robinson, M Harris, W Harvey, N Papadogeorgakis
Metabolic Bone Disease and Related Research 1982
Disorders of Mineral Metabolism
RK Rude, FR Singer
Disorders of Mineral Metabolism 1982
Endokrinologie des Kindes- und Jugendalters
H Stolecke
1982
Endotoxin inhibition of macrophage-mediated bone resorption
AJ Kahn, SL Teitelbaum
Calcified Tissue International 1981
The Bone Inductive Capacity of Decalcified Bone Matrix Modified by Diphenylhydantoin
J Oikarinen
Acta Orthopaedica 1981
Vitamin D Assessment: The Assays and Their Applications
WE Duncan, JG Haddad
Clinics in Laboratory Medicine 1981
Influence of Diphenylhydantoin on Lysosomal Enzyme Release during Bone Resorption in Vitro
U Lerner, L Hänström
Acta Pharmacologica et Toxicologica 1980
Parathyroid hormone stimulates bone resorption via a Na–Ca exchange mechanism
NS Krieger, AH Tashjian
Nature 1980
6 Drug-induced disorders of vitamin D and mineral metabolism
TJ Hahn
Clinics in Endocrinology and Metabolism 1980
Ouabain Effects on Hormonally-Stimulated Bone Resorption and Cyclic AMP Content in Cultured Fetal Rat Bones
TJ Hahn, TF Debartolo, LR Halstead
Endocrine Research 1980
Phenobarbital-induced Alterations in the Metabolism of [3H]Vitamin D3 by the Perfused Rachitic Rat Liver In Vitro
DT Baran, AC Fausto, ML Roberts, I Karl, LV Avioli
Journal of Clinical Investigation 1979
Anticonvulsant drug-induced osteomalacia: Alterations in mineral metabolism and response to vitamin D3 administration
TJ Hahn, LR Halstead
Calcified Tissue International 1979
Disordered mineral metabolism produced by ketogenic diet therapy
TJ Hahn, LR Halstead, DC DeVivo
Calcified Tissue International 1979
Effect of lithium on parathyroid hormone-induced calcium release from bone rudiments
DT Baran, JK Burks, CA Richardson, JB Hamilton, LR Halstead, TJ Hahn, SL Teitelbaum, LV Avioli
Calcified Tissue International 1979
Cortisol enhancement of PTH-stimulated cyclic AMP accumulation in cultured fetal rat long bone rudiments
TJ Hahn, LR Halstead
Calcified Tissue International 1979
Symposium report — drugs and nutrition
AD Kenny
Trends in Pharmacological Sciences 1979
The effect of diphenylhydantoin upon the biosynthesis and degradation of collagen in cat palatal mucosa in organ culture
A Bergenholtz, L Hänström
Biochemical Pharmacology 1979

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts